Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2017-07-27
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to evaluate the effectiveness of Avastin® in
combination with docetaxel and carboplatin in the treatment of lung cancer. The safety of
this combination will also be studied.